WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2024-04-179,520$65.40
$622.61kSell
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2024-04-165,834$66.20
$386.21kSell
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2024-04-157,414$66.33
$491.77kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2024-04-12250$67.79
$16.95kSell
Stephen P. CareySVP CFO2024-04-104,534$66.96
$303.60kSell
James G. MarkenSVP OPS PROD DEV2024-04-102,799$66.96
$187.42kSell
Chad GassertSVP - CORP. DEV. STRATEGY2024-04-0120,000$67.25
$1.35MSell
James G. MarkenSVP OPS PROD DEV2024-03-233,653$69.58
$254.18kSell
Nikhil LalwaniPRESIDENT CEO2024-03-2317,455$69.58
$1.21MSell
Stephen P. CareySVP CFO2024-03-236,210$69.58
$432.09kSell

1 of 12

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners Ii LP88.89%18,737,728$1.23BInsider
Robert E. Brown Jr.80.49%16,967,490$1.11BInsider
Ross J. Mangano27.48%5,792,084$379.27MInsider
Blackrock Inc11.98%2,524,893$165.33MInstitution
Tracy Marshbanks10.95%2,308,568$151.17MInsider
Vanguard Group Inc6.11%1,288,972$84.40MInstitution
Rubric Capital Management LP5.34%1,125,000$73.67MInstitution
Victor A. Morgenstern4.44%936,014$61.29MInsider
Muthusamy Shanmugam4.22%888,504$58.18MInsider
Deep Track Capital LP2.85%600,000$39.29MInstitution

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP21.93%78.07%Net SellingNet Selling
TLRY8.97%1.99%Net Buying
DVAX71.63%28.37%Net SellingNet Selling
PCRX68.56%31.44%Net SellingNet Selling
IRWD72.14%27.86%Net SellingNet Selling
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 64.50% institutional shareholders, 229.59% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners Ii LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 88.89% of the company. Meridian Venture Partners Ii LP's Ani Pharmaceuticals shares are currently valued at $1.21B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.